Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer

E-ISSN： 1876-1038|11|4|297-305

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.11, Iss.4, 2016-10, pp. : 297-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune checkpoint inhibitors in advanced non–small cell lung cancer

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 248-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Review of Recent Clinical Trials

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 117-120

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Pathology of Non-Small-Cell Lung Cancer

Respiration, Vol. 72, Iss. 3, 2005-06 ,pp. : 313-330

Karger

Access to resources Recommend Favorite

Hycamtin in the Therapy of Non-Small-Cell Lung Cancer

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

Combining EGF receptor inhibitors with chemotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

By Bastos Bruno R Lilenbaum Rogerio C

Therapy, Vol. 8, Iss. 1, 2011-01 ,pp. : 9-14

Future Medicine

Access to resources Recommend Favorite